FiercePharma

Merck's Keytruda snags 40th US indication, leaps ahead of GSK with broad endometrial cancer approval

First-line endometrial cancer marks the 40th indication for Keytruda in the U.S. (mattjeacock/iStock/Getty Images Plus) The world’s best-selling medicine is still ...
FiercePharma

Merck's Keytruda flunks pivotal studies in early-stage lung and skin cancers

Merck announced that two phase 3 studies of its PD-1 inhibitor Keytruda have failed. (iStock / Getty Images Plus) A Merck & Co. effort to move its PD-1 behemoth Keytruda into early treatment of lung ...